Clinical Trial Update: Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating estrogen use to minimize recurrence of vaginal prolapse after surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystocele
• Pelvic Floor Disorders
• Pelvic Organ Prolapse
• Urogenital Prolapse
• Uterine Prolapse
• Vaginal Prolapse
• Vaginal Vault Prolapse

Drugs mentioned

• Estrogen (Estrogen)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Pelvic Organ Prolapse, Urogenital Prolapse | Phase 4 | Status: COMPLETED | Results posted: 2022-12-16